* Illumina Inc ILMN.OQ reported quarterly adjusted
earnings of
14 cents per share for the quarter ended in December,
identical to the same quarter last year. The mean expectation
of twenty analysts for the quarter was for earnings of 2 cents
per share. Wall Street expected results to range from -11 cents
to 18 cents per share.
* Revenue rose 3.6% to $1.12 billion from a year ago;
analysts
expected $1.09 billion.
* Illumina Inc's reported EPS for the quarter was a loss of
$1.11.
* The company reported a quarterly loss of $176 million.
* Illumina Inc shares had risen by 2.7% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 89.8%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 12
"hold" and 3 "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "hold"
Wall Street's median 12-month price target for Illumina Inc is
$144.00
This summary was machine generated from LSEG data February 8 at
10:57 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 0.02 0.14 Beat
Sep. 30 2023 0.12 0.33 Beat
Jun. 30 2023 0.02 0.32 Beat
Mar. 31 2023 0.03 0.08 Beat